ImageneBio, Inc. Financial Flexibility Index
ImageneBio, Inc. financial flexibility index. ImageneBio, Inc. (IMA) has a Financial Flexibility Index of -0.91x as of June 2026. Free cash flow of $-9.07 Million (operating CF $-9.07 Million minus capex $0.00) represents -1% of total liabilities ($9.97 Million). See how much free cash does ImageneBio, Inc. generate to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of ImageneBio, Inc. (2018–2025)
Financial flexibility index of ImageneBio, Inc. from 2018 to 2025. Historical Financial Flexibility Index trend for ImageneBio, Inc. across 8 annual periods. Check ImageneBio, Inc. (IMA) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
ImageneBio, Inc. Financial Flexibility Index by Year (2018–2025)
ImageneBio, Inc. financial flexibility index by year from 2018 to 2025. Year-by-year free cash flow to debt coverage for ImageneBio, Inc.. For the full cash flow conversion analysis, see IMA cash generation efficiency.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.41x | $-47.84 Million | $-47.84 Million | $19.84 Million | ▲ +18.3% |
| 2024 | -2.95x | $-46.00 Million | $-46.00 Million | $15.58 Million | ▲ +16.8% |
| 2023 | -3.55x | $-79.33 Million | $-79.74 Million | $22.34 Million | ▼ -23.6% |
| 2022 | -2.87x | $-72.68 Million | $-74.11 Million | $25.29 Million | ▼ -96.5% |
| 2021 | -1.46x | $-58.49 Million | $-60.25 Million | $40.00 Million | ▼ -963.1% |
| 2020 | -0.14x | $-37.06 Million | $-37.83 Million | $269.45 Million | ▼ -142.0% |
| 2019 | 0.33x | $48.24 Million | $47.93 Million | $147.44 Million | ▲ +292.6% |
| 2018 | -0.17x | $-11.30 Million | $-11.61 Million | $66.52 Million | — |